RGEN Q2 2022 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$208M+27.4% YoY

Gross Profit

$121M58.5% margin

Operating Income

$63M30.4% margin

Net Income

$50M24.0% margin

EPS (Diluted)

$0.88

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

$46M

Free Cash Flow

$20M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$640M

Stockholders' Equity

$1.8B

Cash & Equivalents

$597M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$208M	$163M	+27.4%
Gross Profit	$121M	$101M	+20.2%
Operating Income	$63M	$48M	+30.9%
Net Income	$50M	$36M	+37.6%

Revenue Segments

Product

$208M100%

Royalty

$36,0000%